SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Elevating the sintering temperature from 850 to 900°C transform the lithium-manganese-rich cathode from solid-solution structure to chemical separated two-phase structure, which is triggered by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback